These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11859033)

  • 21. Potential autoimmune encephalitis following yellow fever vaccination: A report of three cases.
    Guedes BF; Ribeiro AF; Pinto LF; Vidal JE; de Oliveira FG; Sztajnbok J; de Oliveira ACP; Simabukuro MM
    J Neuroimmunol; 2021 Jun; 355():577548. PubMed ID: 33780799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The US-Certified Yellow Fever Vaccination Center Registry: a tool for travelers, state health departments, and vaccine providers.
    Russell MN; Cetron MS; Eidex RB
    J Travel Med; 2006; 13(1):48-9. PubMed ID: 16412108
    [No Abstract]   [Full Text] [Related]  

  • 23. Yellow fever - prevention in travellers.
    Neilson AA; Mayer CA
    Aust Fam Physician; 2010 Aug; 39(8):570-3. PubMed ID: 20877751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.
    Wkly Epidemiol Rec; 2013 Jul; 88(27):269-83. PubMed ID: 23909008
    [No Abstract]   [Full Text] [Related]  

  • 25. Yellow fever vaccine. WHO position paper.
    World Health Organization
    Wkly Epidemiol Rec; 2003 Oct; 78(40):349-59. PubMed ID: 14569711
    [No Abstract]   [Full Text] [Related]  

  • 26. History of thymoma and yellow fever vaccination.
    Barwick Eidex R;
    Lancet; 2004 Sep 11-17; 364(9438):936. PubMed ID: 15364184
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse events following yellow fever vaccination.
    Wkly Epidemiol Rec; 2001 Jul; 76(29):217-8. PubMed ID: 11488091
    [No Abstract]   [Full Text] [Related]  

  • 28. Yellow fever-associated viscerotropic disease in Barcelona, Spain.
    Muñoz J; Vilella A; Domingo C; Nicolas JM; de Ory F; Corachan M; Tenorio A; Gascon J
    J Travel Med; 2008; 15(3):202-5. PubMed ID: 18494699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yellow fever vaccine: worthy friend or stealthy foe?
    Seligman SJ; Casanova JL
    Expert Rev Vaccines; 2016 Jun; 15(6):681-91. PubMed ID: 27087465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anterior and Intermediate Uveitis Following Yellow Fever Vaccination with Fractional Dose: Case Reports.
    Biancardi AL; Moraes HV
    Ocul Immunol Inflamm; 2019; 27(4):521-523. PubMed ID: 30153765
    [No Abstract]   [Full Text] [Related]  

  • 31. Current status of the Arilvax; yellow fever vaccine.
    Barrett AD
    Expert Rev Vaccines; 2004 Aug; 3(4):413-20. PubMed ID: 15270646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-NMDAR encephalitis as a serious adverse event probably related to yellow fever vaccination].
    Hozáková L; Slonková J; Blahutová Š
    Klin Mikrobiol Infekc Lek; 2018 Mar; 24(1):17-19. PubMed ID: 30016535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse event reports following yellow fever vaccination, 2007-13.
    Lindsey NP; Rabe IB; Miller ER; Fischer M; Staples JE
    J Travel Med; 2016 May; 23(5):. PubMed ID: 27378369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case Report: Fatal Viscerotropic Disease in a Young Woman Following Yellow Fever Vaccination.
    Brunaldi MO; Silva RJC; Fabro AT; de Almeida E Araujo DC; Basile-Filho A; Auxiliadora-Martins M; Menegueti MG; Beloddi MI; Alves Esposito DL; Lopes da Fonseca BA
    Am J Trop Med Hyg; 2021 Sep; 105(6):1803-1805. PubMed ID: 34491221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease and yellow fever.
    Gualandro DM; Bellei N; Oliveira MT; Montenegro S
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):1-2. PubMed ID: 29561932
    [No Abstract]   [Full Text] [Related]  

  • 36. Yellow fever fact sheet.
    Wkly Epidemiol Rec; 2010 Jan; 85(5):33-6. PubMed ID: 20151492
    [No Abstract]   [Full Text] [Related]  

  • 37. Review of the risks and benefits of yellow fever vaccination including some new analyses.
    Monath TP
    Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yellow fever vaccination: some thoughts on how much is enough [Vaccine 23 (2005) 3908-3914].
    Martins RM; Galler R; Freire MS; Camacho LA; de Lourdes S Maia M; Homma A
    Vaccine; 2007 Jan; 25(1):10-1. PubMed ID: 16448728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case suspected for yellow fever vaccine-associated viscerotropic disease in the Netherlands.
    van de Pol EM; Gisolf EH; Richter C
    J Travel Med; 2014; 21(6):421-4. PubMed ID: 24920138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations.
    Who
    Vaccine; 2015 Jan; 33(1):76-7. PubMed ID: 24852721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.